Literature DB >> 28508197

Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs.

O A Lyubashina1, I I Busygina2, S S Panteleev2, A D Nozdrachev2.   

Abstract

We have demonstrated that activation of 5-HT1A receptors with buspirone promotes visceral analgesia in awake dogs. The administration of 0.035 mg/kg (i.m.) of the drug caused depression of viscero-motor (contraction of the abdominal muscles) and pressor (increase in the heart rate) responses to noxious distension of the large intestine. An increase in the dose to 0.07 and 0.14 mg/kg did not enhance the antinociceptive effect of buspirone but triggered basal tachycardia. The obtained results provide evidence of the inhibitory role of 5-HT1A receptors in modulating visceral pain sensitivity and the possibility of an exciting effect of their activation on the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28508197     DOI: 10.1134/S0012496617020119

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  10 in total

1.  The effect of 5-HT1A receptor stimulation on nociceptive dorsal horn neurones in rats.

Authors:  J Gjerstad; A Tjolsen; K Hole
Journal:  Eur J Pharmacol       Date:  1996-12-30       Impact factor: 4.432

2.  The role of 5-HT1A receptors in research strategy for extensive pain treatment.

Authors:  Juan A Mico; Esther Berrocoso; Antonio Ortega-Alvaro; Juan Gibert-Rahola; M Olga Rojas-Corrales
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

3.  Pronociceptive effect of 5-HT(1A) receptor agonist on visceral pain involves spinal N-methyl-D-aspartate (NMDA) receptor.

Authors:  A Mickle; P Kannampalli; M Bruckert; A Miranda; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 4.  The therapeutic potential of 5-HT1A receptors: a patent review.

Authors:  Enza Lacivita; Pantaleo Di Pilato; Paola De Giorgio; Nicola A Colabufo; Francesco Berardi; Roberto Perrone; Marcello Leopoldo
Journal:  Expert Opin Ther Pat       Date:  2012-07-13       Impact factor: 6.674

5.  Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat.

Authors:  Digavalli V Sivarao; Kimberly Newberry; Nicholas J Lodge
Journal:  Eur J Pharmacol       Date:  2004-06-21       Impact factor: 4.432

6.  The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats.

Authors:  E Lindström; A Ravnefjord; M Brusberg; S Hjorth; H Larsson; V Martinez
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

7.  Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.

Authors:  Heather J Chial; Michael Camilleri; Irene Ferber; Silvia Delgado-Aros; Duane Burton; Sanna McKinzie; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2003-05       Impact factor: 11.382

8.  Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat.

Authors:  T J Ness; G F Gebhart
Journal:  Brain Res       Date:  1988-05-31       Impact factor: 3.252

9.  Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.

Authors:  Douglas A Drossman; Mervyn Danilewitz; Jørgen Naesdal; Clara Hwang; John Adler; Debra G Silberg
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

10.  Decrease in gastric sensitivity to distension by 5-HT1A receptor agonists in rats.

Authors:  M L Rouzade; J Fioramonti; L Bueno
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  10 in total
  2 in total

Review 1.  The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System.

Authors:  Zhuo-Ying Tao; Pei-Xing Wang; Si-Qi Wei; Richard J Traub; Jin-Feng Li; Dong-Yuan Cao
Journal:  Neural Plast       Date:  2019-12-17       Impact factor: 3.599

2.  Are Psychotropic Medications Effective in Chronic Pain Management in Children and Adolescents? A Meta-Analysis of Randomized Control Trials.

Authors:  Taranjeet Jolly; Zeeshan Mansuri; Chintan Trivedi; Mahwish Adnan; Steven P Cohen; To-Nhu Vu
Journal:  J Pain Res       Date:  2021-06-24       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.